You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-Nizubaglustat
Nizubaglustat

Chemical Structure : Nizubaglustat

CAS No.: 1633666-49-5

Nizubaglustat (AZ-3102, AZ3102)

Catalog No.: PC-20061Not For Human Use, Lab Use Only.

Nizubaglustat (AZ-3102) is a potent, selective inhibitor of glucosylceramide synthase (GCS) with IC50 of 25 nM, inhibits acid glucosylceramidase (GBA1) and neutral glucosylceramidase (GBA2) with IC50 of 200 and 0.08 nM, respectively.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    Nizubaglustat (AZ-3102) is a potent, selective inhibitor of glucosylceramide synthase (GCS) with IC50 of 25 nM, inhibits acid glucosylceramidase (GBA1) and neutral glucosylceramidase (GBA2) with IC50 of 200 and 0.08 nM, respectively.

    Physicochemical Properties

    M.Wt 433.52
    Formula C24H32FNO5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (2S,3R,4R,5S)-1-(5-((2-fluoro-[1,1'-biphenyl]-4-yl)methoxy)pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol

    References

    1. Amar T Ghisaidoobe, et al. J Med Chem. 2014 Nov 13;57(21):9096-104.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: